Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...

A decade after his landmark Supreme Court case, Jim Obergefell reveals how he lost the man he loved and warns that same-sex ...

Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a study published in Neuron, ...

As Oklahoma lawmakers consider House Bill 1278, which aims to fund research and care for those battling Amyotrophic Lateral ...

Hundreds of thousands of users are laughing at Brooke Eby's comedy and rooting for her as she battles a terminal illness.

Sen. Tammy Baldwin (D-Wis.) and Sen. Peter Welch (D-Vt.) will host a forum on Wednesday, March 26, to discuss how delayed NIH ...

A cholesterol receptor protein called LDLR appears to be a key driver of neurotoxicity in sporadic ALS, per new research ...

BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the confirmatory Phase 3 RESTORE-ALS tr ...

Certain subsets of immune NK cells were altered in the blood of people with ALS, and could serve as therapeutic targets, a ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease ..